In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Inc.

http://www.pfizer.com

Latest From Pfizer Inc.

Sarepta’s Exondys 51 Successor On Clinical Hold, But Quick Resolution Expected

The FDA placed a hold on the Phase II study of SRP-5051, which uses the company’s next-generation peptide conjugation technology, but Sarepta thinks it can address safety questions in short order.

Drug Safety Clinical Trials

Moderna’s Pediatric COVID Vaccine Packaging Spurs Confusion Concerns From CDC Panel

Discrete packaging for authorized dose in 6-11 year-olds is not yet available, so vaccination providers have to use product from a vial labeled for ‘booster doses only’ in adults. ACIP members unanimously endorse use of the mRNA vaccine in individuals ages 6-17 years but urge manufacturers to move away from relying on color to differentiate formulations.

Coronavirus COVID-19 Vaccines

Are Market Conditions Setting Up A Biopharma M&A Wave?

A new EY report contends that declining biotech valuations and the need for large pharma to add pipeline assets may create conditions for a buyer’s market – although year-to-date M&A activity has been lackluster.

M & A Business Strategies

Shionogi Hit By Surprise Japan Road Bump For Oral COVID Drug

After months of speculation and anticipation, Shionogi’s once-daily oral antiviral for the treatment of COVID-19 has stumbled after receiving an unexpected preliminary decision on its emergency approval from an advisory committee in Japan.

Japan Approvals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Agouron Pharmaceuticals
    • Alpharma Pharmaceuticals LLC
    • American Home Products
    • Amplyx Pharmaceuticals, Inc.
    • Anacor Pharmaceuticals, Inc.
    • Array BioPharma, Inc. (ARRY)
    • Arixa Pharmaceuticals, Inc. Bamboo Therapeutics, Inc.
    • Bioren, Inc,
    • Coley Pharmaceutical Group, Inc.
    • CovX Pharmaceuticals, Inc
    • C.P. Pharmaceuticals International C.V.
    • Encysive Pharmaceuticals
    • Excaliard
    • FoldRx Pharmaceuticals, Inc.
    • Ferrosan Consumer Health
    • GD Searle
    • Hisun-Pfizer Pharmaceuticals Co., Ltd.
    • Hospira, Inc.
    • Icagen, Inc.
    • Idun Pharmaceuticals, Inc.
    • InnoPharma
    • Javelin Pharmaceuticals, Inc.
    • King Pharmaceuticals, Inc.
    • Lederle Laboratories
    • Mayne Pharma Limited
    • Meridica Limited
    • Neusentis
    • Parke-Davis
    • Pharmacia
    • Pharmacia and Upjohn Co.
    • PHT Pharma S.r.l.
    • Powdermed
    • Redvax GmbH
    • ReViral Ltd.
    • Serenex
    • Strato Medical Corp.
    • SUGEN
    • Texas Biothechnology Corporation
    • Thiakis Limited
    • Vicuron Pharmaceuticals
    • ViiV Healthcare
    • Warner-Lambert
    • Wyeth
    • Wyeth-Ayerst Laboratories, Inc.
    • Treerly Health Co., Ltd.
    • Meridian Medical Technologies Inc.
    • Montreal, Inc.
    • Medivation, Inc.
    • Sugen LLC
    • Therachon Holding AG.
    • Jones Pharma Inc.
    • Trillium Therapeutics Inc.
UsernamePublicRestriction

Register